glp-1 perimenopause GLP-1s and Hormone Therapy: A Game-Changing Duo for Menopause Belly Fat GLP-1 Weight Loss in Menopause:

3,4-Dihydro-5 [4-(1-piperindinyl)butoxy]-1 (2H)-isoquinoline (DPQ) specifically inhibits PARP1 and has been reported to reduce tumor formation and size in skin carcinogenesis models 168

Unfortunately, that's not how biology works

When combined with the exclusion of patients with either acute or chronic pancreatitis from prior clinical trials, this observation aligns with the caution raised by the American Diabetes Association to avoid use of GLP-1RAs for patients with any history of acute or chronic pancreatitis 27

On average, GLP-1 users may lose 1015% of their body weight over the course of a year

Aoshiba, K., Yokohori, N

For other women, delivery is through a C-section, and that comes with another kind of recovery